As observed for blood samples, the detection rate of CK20 mRNA in bone marrow was slightly lower by trend in patients with adenocarcinomas (detection rate 24.14%), than in those with squamous cell carcinomas (detection rate 35.48%) (Table 4). Here, KRT20 is linked to squamous cell carcinoma.